Adverse Maternal and Fetal Outcomes in Pregnancies Complicated by Diabetes Mellitus: A Case Series
Abstract:
Pregnancy-related diabetes mellitus poses an increased
risk of detrimental effects on the health of the mother and fetus. This case
series aims to highlight the correlation between poorly managed diabetes and
complications such as intrauterine fetal death (IUFD), preterm labor,
macrosomia, and neonatal death. We analyzed cases of pregnant women with
diabetes mellitus who experienced adverse outcomes within one year at our
hospital. The cases were selected based on the seriousness of complications and
gestational period at the time of occurrence. Three cases such cases were
selected, IUFD was experienced by a 30-year-old woman with a gestational age of
36 weeks;a woman whose age was 29 years also experienced IUFD; whose
gestational age was 37 weeks during the occurrence; and another case involved
of a mother whose age was 34 and was at 3 months and 4 days of gestation, who
underwent preterm delivery leading to neonatal death on the first postoperative
day following the surgery. This critical nature of handling diabetes during
pregnancy is emphasized in this case series to mitigate the adverse effects and
the risks which include, IUFD, premature birth, macrosomia, and neonatal death.
Along with continuous monitoring and glycaemic control, to avoid outcomes of complications
caused by diabetes mellitus during pregnancy educating the patient is also very
important.
References:
[1]. Home R., 2024. Gestational Diabetes Mellitus, IDF
Diabetes Atlas, 11, 2024.
[2]. Coustan, D. R., 2013. Gestational
Diabetes Mellitus, Clin. Chem.,
59, 1310–1321.
[3]. McIntyre, H. D.,
Catalano, P., Zhang, C., Desoye, G.,
Mathiesen, E. R., and Damm, P., 2019. Gestational diabetes mellitus, Nat. Rev. Dis. Primer, 5,
1–19.
[4]. Hod. M et al., 2015. The International
Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational
diabetes mellitus: A pragmatic guide for diagnosis, management, and care, Int. J. Gynaecol. Obstet. Off. Organ Int.
Fed. Gynaecol. Obstet.,
131, 173-211.
[5]. Gupta, Y., Goyal, A.,
Kalra, S., and Tandon, N., 2020. Variation in the classification of
hyperglycaemia in pregnancy and its implication, Lancet Diabetes Endocrinol., 8, 264–266.
[6]. Metzger, B. E., Gabbe,
S. G., Persson, B., Buchanan, T. A., Catalano, P. A., Damm, P., Dyer, A. R.,
Leiva, Ad., Hod, M., Kitzmiler, J. L., Lowe, L. P., McIntyre, H. D., Oats, J.
J., Omori, Y., Schmidt, M. I., 2010. International Association of Diabetes and Pregnancy Study Groups
Consensus Panel, International Association of Diabetes and Pregnancy Study
Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in
Pregnancy, Diabetes Care, 33, 676–682.
[7]. Metzger, B. E., Lowe,
L. P., Dyer, A. R., Trimble, E. R., Chaovarindr, U., Coustan, D. R., Hadden, D.
R., McCance, D. R., Hod, M., McIntyre, H. D., Oats, J. J., Persson, B., Rogers,
M. S., Sacks, D. A., 2008. Hyperglycemia and Adverse Pregnancy Outcomes | New England
Journal of Medicine. 16,115-144.
[8]. Goyal, A., Gupta, Y.,
and Tandon, N., 2022. Overt Diabetes in
Pregnancy, Diabetes Ther., 13,
589–600.
[9]. Wong, T., Ross, G. P.,
Jalaludin, B. B., and Flack, J. R., 2013. The clinical significance of overt
diabetes in pregnancy, Diabet. Med. J.
Br. Diabet. Assoc.,
30, 468–474.
[10]. Corrado, F., Pintaudi,
B., D’Anna, R., Santamaria, A., Giunta, L., and Di Benedetto, A., 2016.
Perinatal outcome in a Caucasian population with gestational diabetes and
preexisting diabetes first diagnosed in pregnancy, Diabetes Metab.,
42, 122–125.
[11]. Egan, A. M., Dow, M. L.,
and Vella, A., 2020. A Review of the Pathophysiology and Management of Diabetes
in Pregnancy, Mayo Clin. Proc., 95,
2734–2746.
[12]. Metz, T. D., Berry, R.
S., Fretts, R. C., Reddy, U. M., and Turrentine, M. A., 2020, Obstetric Care
Consensus Management of Stillbirth: (Replaces Practice Bulletin
Number 102, March 2009), Am. J. Obstet.
Gynecol., 222, B2–B20.
[13]. Maslovich, M. M., and
Burke. L. M., 2024. Intrauterine Fetal Demise, in StatPearls, 35, 2091–2098.
[14]. Bekiou, A., and
Gourounti. K., 2020. Reduced Fetal Movements and Perinatal Mortality, Mater. Socio-Medica, 32,
227–234.
[15]. Lynch, T. A., Westen,
E., Li, D., Katzman, P. J., Malshe, A., and Drennan, K., 2022. Stillbirth in
women with diabetes: a retrospective analysis of fetal autopsy reports, J. Matern. Fetal Neonatal Med.,35, 2091–2098.
[16]. Dayal, S., and Hong, P.
L., 2024. Premature Rupture of Membranes, in StatPearls, Treasure Island (FL): StatPearls Publishing. Accessed:
Aug. 11, 2024.
[17]. Muche, A. A., Olayemi,
O. O., and Gete, Y. K., 2020. Effects of gestational diabetes mellitus on risk
of adverse maternal outcomes: a prospective cohort study in Northwest Ethiopia, BMC Pregnancy Childbirth,
20, 73.
[18]. Bouvier, D et al., 2019. Risk Factors and Outcomes
of Preterm Premature Rupture of Membranes in a Cohort of 6968 Pregnant Women
Prospectively Recruited, J. Clin. Med., 8,
1987.
[19]. Yildiz Atar, H., Baatz,
J. E., and Ryan, R. M., 2021. Molecular Mechanisms of Maternal Diabetes Effects
on Fetal and Neonatal Surfactant, Children, 8,
281.
[20]. Li, Y., Wang, W., and
Zhang, D., 2019. Maternal diabetes mellitus and risk of neonatal respiratory
distress syndrome: A meta-analysis,
Acta Diabetol., 56, 729–740.
[21]. Shanmugam, R., Tharani,
M., Abullais, S.S., 2024. Black seed assisted synthesis, characterization, free
radical scavenging, antimicrobial and anti-inflammatory activity of iron oxide
nanoparticles. BMC Complement Med Ther 24(24), 241.
[22]. Habeeb Rahuman HB.,
Dhandapani R., Narayanan S., Palanivel V., Paramasivam R., Subbarayalu R.,
Thangavelu S., Muthupandian S., 2022. Medicinal plants mediated the green
synthesis of silver nanoparticles and their biomedical applications. IET
Nanobiotechnol. 16,115-144.
[23]. Wadhwa R., Paudel KR.,
Chin LH., Hon CM., Madheswaran T., Gupta G., Panneerselvam J., Lakshmi T.,
2021. Anti-inflammatory and anticancer activities of Naringenin-loaded liquid
crystalline nanoparticles in vitro. J Food Biochem. 45, 13572.
